Restricting α-Synuclein Transport into Mitochondria by Inhibition of α-Synuclein-VDAC Complexation as a Potential Therapeutic Target for Parkinson’s Disease Treatment

Megha Rajendran; Tatiana K. Rostovtseva

doi:10.1101/2022.04.07.487541

Restricting α-Synuclein Transport into Mitochondria by Inhibition of α-Synuclein-VDAC Complexation as a Potential Therapeutic Target for Parkinson’s Disease Treatment

Megha Rajendran(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Tatiana K. Rostovtseva(National Institutes of Health)

bioRxiv (Cold Spring Harbor Laboratory)

April 8, 2022

10.1101/2022.04.07.487541

Cited by 0

|Current Protocols in Cytometry|2014|25

Restricting α-Synuclein Transport into Mitochondria by Inhibition of α-Synuclein-VDAC Complexation as a Potential Therapeutic Target for Parkinson’s Disease Treatment

Related Papers